×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLRZ – polyrizon ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLRZ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
09:23 am
plrz
Polyrizon Provides 2025 and Recent Highlights
Low
Report
Polyrizon Provides 2025 and Recent Highlights
3/25
05:36 pm
plrz
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 [TheStreet.com]
Medium
Report
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 [TheStreet.com]
3/25
05:25 pm
plrz
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
Low
Report
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
3/24
08:47 am
plrz
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications
Medium
Report
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications
3/17
08:25 am
plrz
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program
Medium
Report
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program
3/10
07:55 am
plrz
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
Medium
Report
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
2/26
08:12 am
plrz
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product
Low
Report
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product
2/17
11:32 am
plrz
Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker
Low
Report
Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
09:03 am
plrz
Form 20-F/A Polyrizon Ltd. For: Dec 31
High
Report
Form 20-F/A Polyrizon Ltd. For: Dec 31
3/25
05:23 pm
plrz
Form 20-F Polyrizon Ltd. For: Dec 31
Low
Report
Form 20-F Polyrizon Ltd. For: Dec 31
3/18
06:46 am
plrz
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Itzhaik Asaf
Low
Report
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Itzhaik Asaf
3/18
06:45 am
plrz
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Sidi Liat
Low
Report
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Sidi Liat
3/18
06:44 am
plrz
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Ron Eyal S
Low
Report
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Ron Eyal S
3/18
06:43 am
plrz
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Vinokur Yehonatan Zalman
Low
Report
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Vinokur Yehonatan Zalman
3/18
06:42 am
plrz
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Carmel Liron
Low
Report
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Carmel Liron
3/18
06:41 am
plrz
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Turgeman Tidhar
Low
Report
Form 3 Polyrizon Ltd. For: Mar 18 Filed by: Turgeman Tidhar
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: